New lipid biomarkers identified for mild cognitive impairment

As people live longer, age-related disorders, including many neurodegenerative diseases, are becoming increasingly common. Dementia currently affects about 55 million people worldwide, and in the absence of effective interventions, this number is projected to rise to 150 million by 2050.